ANTI-ALZHEIMER ACTIVITY OF TACRINE LOADED METHOXYPOLY (ETHYLENE GLYCOL) POLY (CAPROLACTONE) NANOPARTICLES
DOI:
https://doi.org/10.22159/ajpcr.2018.v11s4.31730Abstract
Objective: The objective of the study was to study the in vitro cytotoxic effects of amyloid-β (Aβ) in SH-SY5Y cells and in vivo therapeutic efficacy of drug-loaded nanoparticles (TMPCN-3) in mice.
Methods: In vitro cytotoxic effects of Aβ in SH-SY5Y cells were carried out using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide assay; cellular uptake study was carried using a laser scanning fluorescence microscope. In vivo therapeutic efficacy of drug loaded nanoparticles, optimized formulation (TMPCN-3) in mice. Animals (n=18) were divided into three different groups each consisting of six animals in each group.
Results: Treatment with Aβ-induced cytotoxicity showed a 54% decrease in cell viability. Drug-treated with TMPCN-3 showed greater intracellular accumulation. In the invasive study TMPCN-3 nanoparticles, the SH-SY5Y cells (73%) were decreased when compared to the control cells (91%). In vivo therapeutic efficacy of drug-loaded nanoparticles was studied in mice, Morris water maze task shows polymeric nanoformulations indicates critical change execution (expanded memory maintenance) when contrasted with control, step down condition maintains a considered space from response created by the memory change and polymeric nanoformulations, and after that taken by tacrine and control the quantity of errors are higher. The nanoformulations distributed massive decreasing in acetylcholine esterase level brain homogenate.
Conclusion: Tacrine-loaded methoxypoly(ethylene glycol) poly(caprolactone) reveals that the in vitro cell line believes emphasized the reduced risk of tacrine loaded nanoparticles as there is a significant decrease half maximal inhibitory concentration and higher convention of drug in the glial cells and by in vivo reflects was confirmed that nanoformulation indicated improved memory.
Downloads
References
Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012;148:1204-22.
Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration : Lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol 2007;8:101-12.
Arispe N, Pollard HB, Rojas E. Beta-amyloid ca(2+)-channel hypothesis for neuronal death in Alzheimer disease. Mol Cell Biochem 1994;140:119-25.
Dong Z, Saikumar P, Weinberg JM, Venkatachalam MA. Calcium in cell injury and death. Annu Rev Pathol 2006;1:405-34.
Grösgen S, Grimm MO, Friess P, Hartmann T. Role of amyloid beta in lipid homeostasis. Biochim Biophys Acta 2010;1801:966-74.
Yu X, Zheng J. Cholesterol promotes the interaction of Alzheimer β-amyloid monomer with lipid bilayer. J Mol Biol 2012;421:561-71.
Schneider A, Schulz-Schaeffer W, Hartmann T, Schulz JB, Simons M. Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons. Neurobiol Dis 2006;23:573-7.
Cui Y, Xu Q, Chow PK, Wang D, Wang CH. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials 2013;34:8511-20.
Li Y, He H, Jia X, Lu WL, Lou J, Wei Y, et al. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials 2012;33:3899-908.
Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47-60.
Barros DM, Ramirez MR, Izquierdo I. Modulation of working, short -and long-term memory by nicotinic receptors in the basolateral amygdala in rats. Neurobiol Learn Mem 2005;83:113-8.
Yu Z, Cheng G, Hu B. Mechanism of colchicine impairment on learning and memory, and protective effect of CGP36742 in mice. Brain Res 1997;750:53-8.
Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with ellman’s reagent. Anal Biochem 1968;25:192-205.
Ismail R, Hansen AK, Parbo P, Brændgaard H, Gottrup H, Brooks DJ, et al. The effect of 40-hz light therapy on amyloid load in patients with prodromal and clinical Alzheimer’s disease. Int J Alzheimers Dis 2018;2018:6852303.
Nishimura S, Murasugi T, Kubo T, Kaneko I, Meguro M, Marumoto S, et al. RS-4252 inhibits amyloid beta-induced cytotoxicity in HeLa cells. Pharmacol Toxicol 2003;93:29-32.
Liu ML, Hong ST. Early phase of amyloid β42-induced cytotoxicity in neuronal cells is associated with vacuole formation and enhancement of exocytosis. Exp Mol Med 2005;37:559-66.
McWilliams-Koeppen HP, Foster JS, Hackenbrack N, Ramirez- Alvarado M, Donohoe D, Williams A, et al. Light chain amyloid fibrils cause metabolic dysfunction in human cardiomyocytes. PLoS One 2015;10:e0137716.
Lai Y, Chiang PC, Blom JD, Li N, Shevlin K, Brayman TG, et al. Comparison of in vitro nanoparticles uptake in various cell lines and in vivo pulmonary cellular transport in intratracheally dosed rat model. Nanoscale Res Lett 2008;3:321-9.
Ansari AA, Hasan TN, Syed NA, Labis JP, Alshatwi AA. In-vitro cytotoxicity and cellular uptake studies of luminescent functionalized core-shell nanospheres. Saudi J Biol Sci 2017;24:1392-403.
Salatin S, Yari Khosroushahi A. Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles. J Cell Mol Med 2017;21:1668-86.
Borba Filho GL, Zenki KC, Kalinine E, Baggio S, Pettenuzzo L, Zimmer ER, et al. A new device for step-down inhibitory avoidance task-effects of low and high frequency in a novel device for passive inhibitory avoidance task that avoids bioimpedance variations. PLoS One 2015;10:e0116000.
Atucha E, Roozendaal B. The inhibitory avoidance discrimination task to investigate accuracy of memory. Front Behav Neurosci 2015;9:60.
Colettis NC, Snitcofsky M, Kornisiuk EE, Gonzalez EN, Quillfeldt JA, Jerusalinsky DA, et al. Amnesia of inhibitory avoidance by scopolamine is overcome by previous open-field exposure. Learn Mem 2014;21:634-45.
Appleyard ME, Taylor SC, Little HJ. Acetylcholinesterase activity in regions of mouse brain following acute and chronic treatment with a benzodiazepine inverse agonist. Br J Pharmacol 1990;101:599-604.
Paul R, Borah A. Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and infammation in brain of hypercholesterolemic mice. Sci Rep 2017;7:17922.
Costa M, Bernardi J, Costa L, Fiuza T, Brandao R, Pereira M. N-acetyl cysteine decreases mice brain acetyl cholinesterase activity: An in vitro kinetic study. Enz Eng 2015;5:1-6.
Ahmed N, Tarannum S. Acetylcholinesterase activity in the brain of alloxan diabetic albino rats: Presence of an inhibitor of this enzyme activity in the cerebral extract. Int J Diabetes Dev Ctries 2009;29:174-7.
Khan RA, Khan MR, Sahreen S. Brain antioxidant markers, cognitive performance and acetylcholinesterase activity of rats: Efficiency of Sonchus asper. Behav Brain Funct 2012;8:21.
Ferreira GK, Carvalho-Silva M, Gonçalves CL, Vieira JS, Scaini G, Ghedim FV, et al. L-tyrosine administration increases acetylcholinesterase activity in rats. Neurochem Int 2012;61:1370-4.
Richetti SK, Rosemberg DB, Ventura-Lima J, Monserrat JM, Bogo MR, Bonan CD, et al. Acetylcholinesterase activity and antioxidant capacity of zebrafish brain is altered by heavy metal exposure. Neurotoxicology 2011;32:116-22.
Vorhees CV, Williams MT. Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006;1:848-58.
Nunez J. Morris water maze experiment. J Vis Exp 2008;19:897.
Snow WM, Pahlavan PS, Djordjevic J, McAllister D, Platt EE, Alashmali S, et al. Morris water maze training in mice elevates hippocampal levels of transcription factors nuclear factor (erythroid-derived 2)-like 2 and nuclear factor kappa B p65. Front Mol Neurosci 2015;8:70.
van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci U S A 1999;96:13427-31.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
